LEARNING OBJECTIVES
• Describe actions Congress and the Administration have recently taken related to the pharmaceutical supply chain and drug pricing
• Give examples of steps government agencies have taken given the May 11, 2023 end to the COVID-19 public health emergency
• Discuss anticipated federal legislative and regulatory issues that will impact pharmacists for the year ahead